Investigation Overview
An investigation on behalf of investors, who currently hold shares of Immune Design Corp. (NASDAQ: IMDZ), was announced concerning whether the takeover of Immune Design Corp. is unfair to NASDAQ: IMDZ stockholders. The investigation by a law firm concerns whether certain officers and directors of Immune Design Corp. breached their fiduciary duties owed to NASDAQ: IMDZ investors in co...
You must register (for free) or login to view the entire investigation.